Among the responses to this imminent threat, phagotherapy, which involves the use of natural viruses, or phages, represents the most promising hope for fighting against microbial infections.
At the forefront of the fight against anti-microbial resistance (AMR).Find out more
Since 2007, Pherecydes Pharma has been developing an innovative therapeutic approach against resistant bacteria.
Anti-microbial resistance (AMR), a slow tsunami!Find out more
The constant threat of antibiotic resistance makes the development of treatments based on bacteriophages all the more important.
Bacteriophages, natural bacteria-killing virusesFind out more
Bacteriophages are harmless to human organisms and specifically kill bacteria in an ultra-targeted way.
A promising therapy
Antibiotics are designed to destroy or inhibit the growth of bacteria. Yet bacteria naturally have resistance mechanism, which has been reinforced over time by the excessive use, as it is still the case today, of antibiotics. According to the World Health Organization (WHO), antibiotic resistance is the number one priority for global health.
1 240 000
deaths directly attributable to antibiotic resistance worldwide in 2019 according to a study published in “The Lancet“
years of research to fight against resistant bacteria
deaths per year by 2050 due to antibiotic resistance according to WHO
patents already filed by Pherecydes Pharma since its creation, some of which have been granted in the United States, Europe, Japan, Hong Kong and Australia